Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Free Report) shares passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.84 and traded as low as $0.56. Pharma-Bio Serv shares last traded at $0.65, with a volume of 240 shares changing hands.
Pharma-Bio Serv Stock Performance
The business’s 50 day moving average price is $0.67 and its 200 day moving average price is $0.84.
Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) last posted its quarterly earnings data on Friday, June 14th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.03 by ($0.04). The firm had revenue of $2.38 million for the quarter, compared to analysts’ expectations of $3.00 million. Pharma-Bio Serv had a negative return on equity of 0.04% and a negative net margin of 0.05%. As a group, research analysts forecast that Pharma-Bio Serv, Inc. will post 0.04 EPS for the current fiscal year.
Pharma-Bio Serv Company Profile
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
Read More
- Five stocks we like better than Pharma-Bio Serv
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- How to Invest in Small Cap Stocks
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- How to Evaluate a Stock Before Buying
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.